Publication related to RSI or an RSI staff member

Risk factors associated with the onset and progression of Alzheimer’s disease: A systematic review of the evidence.

Authors

  • Hersi, Mona, Hersi M, McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada; School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: mhersi@ohri.ca.

  • Irvine, Brittany, Irvine B, McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada.

  • Gupta, Pallavi, Gupta P, McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada.

  • Gomes, James, Gomes J, McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada; Environmental Health Research Unit, University of Ottawa, ON, Canada; Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, ON, Canada.

  • Birkett, Nicholas, Birkett N, McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada; School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

  • Krewski, Daniel, Krewski D, McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada; School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Risk Sciences International, Ottawa, Ontario Canada.

YEAR OF PUBLICATION: 2017
SOURCE: Neurotoxicology. 2017 Jul;61:143-187. doi: 10.1016/j.neuro.2017.03.006. Epub 2017 Mar 29.
JOURNAL TITLE ABBREVIATION: Neurotoxicology
JOURNAL TITLE: Neurotoxicology
ISSN: 1872-9711 (Electronic) 0161-813X (Linking)
VOLUME: 61
PAGES: 143-187
PLACE OF PUBLICATION: Netherlands
ABSTRACT:

A systematic review was conducted to identify risk factors associated with the onset and progression of Alzheimer's disease (AD). Moderate and high quality systematic reviews were eligible for inclusion. Primary studies reporting on non-genetic risk factors associated with neuropathologically or clinically confirmed AD were considered. Eighty one systematic reviews reporting on AD onset and 12 reporting on progression satisfied the eligibility criteria. Four hundred and thirty-two relevant primary studies reporting on onset were identified; however, only those published between 2010 and 2012 (n=65) were included in the qualitative synthesis. Several factors including statins, light-to-moderate alcohol consumption, compliance with a Mediterranean diet, higher educational attainment, physically and cognitively stimulating activities, and APOE epsilon2 appeared to be associated with a decreased risk of AD onset. The evidence was suggestive of an increased risk of AD associated with head injury in males, age, diabetes mellitus, conjugated equine estrogen use with medroxyprogesterone acetate, current smoking, and lower social engagement. With respect to genetic factors, APOE epsilon4 remained the strongest predictor of AD. Physical and cognitive activities were associated with a beneficial effect on cognitive function and other indicators of dementia progression while higher educational attainment was associated with faster cognitive decline. Although suggestive of an association, the current evidence for a majority of the identified putative factors for AD onset and progression was weak, at best due to conflicting findings across studies or inadequate evidence. Further research is required to confirm the etiological or protective role of a number of risk factors.

COPYRIGHT INFORMATION: Copyright (c) 2017. Published by Elsevier B.V.
LANGUAGE: eng
DATE OF PUBLICATION: 2017 Jul
DATE OF ELECTRONIC PUBLICATION: 20170329
DATE COMPLETED: 20180508
DATE REVISED: 20250623
MESH DATE: 2018/05/09 06:00
EDAT: 2017/04/02 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: S0161-813X(17)30055-4 [pii] 10.1016/j.neuro.2017.03.006 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski